Matt Williams and Emma Fisher’s $1 billion Australian Share Fund returned just 3.2 per cent last year as it avoided the rally in gold stocks and got hit by a sell-off in CSL.
DONGGUAN, GUANGDONG, CHINA, January 13, 2026 /EINPresswire.com/ -- Globally, the medical industry is undergoing a major ...
As the calendar flips to a new year, so many of us set bold goals to exercise more, stress less, eat better, and live with a ...
Industry Trends and Wellness Market Expansion The retail wellness market is currently experiencing an astounding ...
DONGGUAN, GUANGDONG, CHINA, January 13, 2026 /EINPresswire.com/ -- Careboo, an innovator in therapeutic technology and ...
Respiratory and sleep medicine physicians share collaborative measures to diagnose and treat comorbid sleep disorders and ...
A nightly oral pill for obstructive sleep apnea is close to regulatory approval in the US. This medicine-based option could transform treatment for millions struggling with device therapies.
With Q3 behind us, let’s have a look at ResMed (NYSE:RMD) and its peers. Patient monitoring companies within the healthcare ...
Inspire Medical Systems’ growth strategy is focused on ensuring strong clinical outcomes, driving manufacturing capabilities, ...
Your kidneys normally concentrate urine at night in response to antidiuretic hormone. If you have kidney problems, the ...
Sleep apnea is increasingly common in India, yet few seek help. Factors like pollution and urban stress worsen sleep quality, leading to serious health risks.
Taking a dark shower could be key to better sleep. Learn more about the evidence behind this pre-bedtime home practice.